GlucoTrack announced that its second-generation glucose monitor device has shown promising results in analyses.
Rutherford, New Jersey-based GlucoTrack — formerly known as Integrity Applications (Nasdaq:IGAP) — earlier this...
Aifred Health, an award-winning digital healthcare company, announced the treatment of the first patient in its 350 patient North American Clinical Trial. This clinical...
GI Dynamics announced the results of a study of its EndoBarrier system that met efficacy and safety endpoints.
Boston-based GI Dynamics designed its EndoBarrier endoscopically delivered...
MedAlliance announced that the first patient was enrolled in a trial of its Selution SLR sirolimus-eluting balloon.
Last month, the company received FDA investigational device exemption (IDE)...
Tandem Diabetes Care announced that real-world data supports its t:slim X2 insulin pump with Control-IQ technology.
Data from the ongoing real-world Control-IQ observational (CLIO) study...
Medtronic announced positive real-world data supporting its next-generation MiniMed 780G insulin pump system.
Results from real-world analyses in Europe and Chile, along with clinical data, were...
- AuriNovo™ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear -
- Phase 1/2a clinical...
Enspectra Health, a digital health company dedicated to pioneering a new field of virtual biopsies, announced that it has launched a pilot feasibility study. The...
HistoSonics, the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced the fulfillment of patient enrollment required for...
